REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 152 filers reported holding REVANCE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 2.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,604,929 | +12.9% | 314,292 | +149.1% | 0.01% | -18.2% |
| Q2 2023 | $3,193,818 | -65.4% | 126,188 | -56.0% | 0.01% | -92.0% |
| Q1 2023 | $9,230,162 | -1.7% | 286,562 | -43.7% | 0.14% | -19.3% |
| Q4 2022 | $9,390,510 | -33.5% | 508,695 | -2.7% | 0.17% | -36.7% |
| Q3 2022 | $14,122,000 | +119.8% | 523,045 | +12.5% | 0.27% | +52.5% |
| Q2 2022 | $6,426,000 | -34.8% | 464,970 | -8.1% | 0.18% | -33.0% |
| Q1 2022 | $9,861,000 | +69.1% | 505,701 | +41.6% | 0.26% | +45.9% |
| Q4 2021 | $5,830,000 | +284.1% | 357,237 | +555.8% | 0.18% | +320.9% |
| Q3 2021 | $1,518,000 | -52.1% | 54,477 | -49.0% | 0.04% | -60.2% |
| Q2 2021 | $3,167,000 | +61.3% | 106,859 | +52.1% | 0.11% | -5.3% |
| Q1 2021 | $1,963,000 | -2.9% | 70,249 | -1.6% | 0.11% | -15.6% |
| Q4 2020 | $2,022,000 | +354.4% | 71,365 | +108.1% | 0.14% | +175.5% |
| Q2 2019 | $445,000 | +1.6% | 34,300 | +94.4% | 0.05% | -76.0% |
| Q3 2018 | $438,000 | – | 17,644 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 3,342,047 | $52,671,000 | 26.22% |
| NovaQuest Capital Management, L.L.C. | 1,558,426 | $24,561,000 | 22.85% |
| Sio Capital Management, LLC | 254,581 | $4,012,000 | 1.08% |
| ArrowMark Colorado Holdings LLC | 3,409,217 | $53,729,000 | 0.51% |
| Fosun International Ltd | 472,532 | $7,447,000 | 0.47% |
| Rhenman & Partners Asset Management AB | 193,181 | $3,045,000 | 0.36% |
| Phoenix Investment Adviser LLC | 4,900 | $77,000 | 0.17% |
| HARBOURVEST PARTNERS LLC | 26,565 | $419,000 | 0.15% |
| Quinn Opportunity Partners LLC | 56,672 | $893,000 | 0.12% |
| MFN Partners Management, LP | 46,000 | $725,000 | 0.12% |